These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 28573615

  • 21. Assessment of Life Cycle Modeling Systems as Prediction Tools for a Possible Attenuation of Recombinant Ebola Viruses.
    Bodmer BS, Hoenen T.
    Viruses; 2022 May 13; 14(5):. PubMed ID: 35632785
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles.
    Yoon YS, Jang Y, Hoenen T, Shin H, Lee Y, Kim M.
    BMB Rep; 2020 Mar 13; 53(3):166-171. PubMed ID: 31964466
    [Abstract] [Full Text] [Related]

  • 25. Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral Compounds.
    Falzarano D.
    Methods Mol Biol; 2017 Mar 13; 1628():203-210. PubMed ID: 28573622
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle.
    Biedenkopf N, Lier C, Becker S.
    J Virol; 2016 May 15; 90(10):4914-4925. PubMed ID: 26937028
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A novel cell culture system modeling the SARS-CoV-2 life cycle.
    Ju X, Zhu Y, Wang Y, Li J, Zhang J, Gong M, Ren W, Li S, Zhong J, Zhang L, Zhang QC, Zhang R, Ding Q.
    PLoS Pathog; 2021 Mar 15; 17(3):e1009439. PubMed ID: 33711082
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J, Geisbert TW.
    Expert Rev Anti Infect Ther; 2006 Feb 15; 4(1):67-76. PubMed ID: 16441210
    [Abstract] [Full Text] [Related]

  • 34. A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle.
    Martin S, Chiramel AI, Schmidt ML, Chen YC, Whitt N, Watt A, Dunham EC, Shifflett K, Traeger S, Leske A, Buehler E, Martellaro C, Brandt J, Wendt L, Müller A, Peitsch S, Best SM, Stech J, Finke S, Römer-Oberdörfer A, Groseth A, Feldmann H, Hoenen T.
    Genome Med; 2018 Aug 07; 10(1):58. PubMed ID: 30081931
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications.
    Nelson EA, Barnes AB, Wiehle RD, Fontenot GK, Hoenen T, White JM.
    Viruses; 2016 Aug 02; 8(8):. PubMed ID: 27490565
    [Abstract] [Full Text] [Related]

  • 37. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.
    Kroeker A, Griffin BD, Qiu X, Kobinger G.
    Methods Mol Biol; 2017 Aug 02; 1628():273-282. PubMed ID: 28573628
    [Abstract] [Full Text] [Related]

  • 38. [Promising approaches of antiviral therapy of hemorrhagic fevers].
    Markin VA.
    Zh Mikrobiol Epidemiol Immunobiol; 2014 Aug 02; (3):114-24. PubMed ID: 25286519
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals.
    Hoenen T, Groseth A, Callison J, Takada A, Feldmann H.
    Antiviral Res; 2013 Sep 02; 99(3):207-13. PubMed ID: 23751367
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.